Coherus Oncology, Inc. (CHRS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 12.31M | 12.75M | 11.57M | 10.25M | 7.6M | 54.14M | 70.77M | 64.98M | 2.31M | 91.52M | 74.57M | 58.72M |
| Revenue Growth % | 61.99% | -76.46% | -83.65% | -84.22% | 229.25% | -40.84% | -5.09% | 10.67% | -92.88% | 101.81% | 64.16% | -2.39% |
| Cost of Goods Sold | 4.7M | 4.94M | 4.69M | 4.41M | 3.7M | 33.86M | 20.74M | 29.55M | 1.44M | 84.57M | 32.7M | 24.85M |
| COGS % of Revenue | 38.14% | 38.76% | 40.51% | 43.02% | 48.68% | 62.53% | 29.31% | 45.48% | 62.35% | 92.4% | 43.86% | 42.32% |
| Gross Profit | 7.62M | 7.81M | 6.88M | 5.84M | 3.9M | 20.29M | 50.03M | 35.42M | 869K | 6.96M | 41.87M | 33.87M |
| Gross Margin % | 61.86% | 61.24% | 59.49% | 56.98% | 51.32% | 37.47% | 70.69% | 54.52% | 37.65% | 7.6% | 56.14% | 57.68% |
| Gross Profit Growth % | 95.26% | -61.52% | -86.24% | -83.51% | 348.79% | 191.59% | 19.51% | 4.59% | -94.42% | -77.67% | 310.84% | -30.7% |
| Operating Expenses | 43.77M | 53.69M | 49.12M | 51.33M | 49.34M | 62.53M | 56.42M | 55.93M | 68.66M | 75.86M | 73.87M | 68.41M |
| OpEx % of Revenue | 355.53% | 421.14% | 424.48% | 500.58% | 649.23% | 115.49% | 79.72% | 86.08% | 2974.7% | 82.89% | 99.07% | 116.51% |
| Selling, General & Admin | 23.1M | 23.61M | 22.83M | 26.04M | 26.02M | 41.3M | 34.74M | 35.16M | 40.23M | 49.49M | 48.22M | 45.14M |
| SG&A % of Revenue | 187.68% | 185.2% | 197.31% | 253.94% | 342.48% | 76.27% | 49.09% | 54.12% | 1743.15% | 54.08% | 64.67% | 76.89% |
| Research & Development | 20.66M | 30.08M | 26.29M | 25.29M | 23.31M | 21.23M | 21.68M | 20.77M | 28.42M | 26.37M | 25.65M | 23.27M |
| R&D % of Revenue | 167.85% | 235.94% | 227.17% | 246.64% | 306.75% | 39.22% | 30.63% | 31.96% | 1231.54% | 28.81% | 34.39% | 39.63% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -36.15M | -45.88M | -42.23M | -45.49M | -45.44M | -42.25M | -6.39M | -20.51M | -67.79M | -68.91M | -32.01M | -34.54M |
| Operating Margin % | -293.67% | -359.9% | -364.99% | -443.59% | -597.91% | -78.03% | -9.02% | -31.56% | -2937.05% | -75.29% | -42.92% | -58.83% |
| Operating Income Growth % | 20.43% | -8.6% | -561.23% | -121.79% | 32.97% | 38.69% | 80.04% | 40.63% | -0.06% | -33.81% | 60.22% | 21.52% |
| EBITDA | -35.27M | -44.98M | -41.27M | -44.47M | -44.39M | -41.21M | -4.84M | -19.32M | -66.28M | -67.84M | -30.37M | -33.66M |
| EBITDA Margin % | -286.51% | -352.87% | -356.64% | -433.68% | -584.14% | -76.12% | -6.84% | -29.74% | -2871.75% | -74.12% | -40.73% | -57.33% |
| EBITDA Growth % | 20.54% | -9.15% | -752.98% | -130.15% | 33.03% | 39.25% | 84.07% | 42.6% | 0.77% | -34.49% | 61.78% | 21.94% |
| D&A (Non-Cash Add-back) | 881K | 896K | 966K | 1.02M | 1.05M | 1.03M | 1.55M | 1.19M | 1.51M | 1.06M | 1.64M | 880K |
| EBIT | -36.15M | -45.88M | -42.23M | -45.49M | -45.44M | -45.35M | -5.39M | -7.59M | -64.92M | -69.03M | -29.75M | -32.93M |
| Net Interest Income | -2.19M | -2.25M | -2.33M | -2.28M | -2.15M | -5.35M | -5.36M | -5.33M | -11.12M | -10.62M | -10.27M | -9.94M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.19M | 2.25M | 2.33M | 2.28M | 2.15M | 5.35M | 5.36M | 5.33M | 11.12M | 10.62M | 10.27M | 9.94M |
| Other Income/Expense | -784K | -467K | -2.28M | 624K | -1.96M | -8.45M | -4.36M | 7.59M | -249K | -10.75M | -8.02M | -8.33M |
| Pretax Income | -36.94M | -46.35M | -44.52M | -44.86M | -47.4M | -50.7M | -10.75M | -12.92M | -68.04M | -79.65M | -40.02M | -42.87M |
| Pretax Margin % | -300.04% | -363.56% | -384.73% | -437.51% | -623.74% | -93.63% | -15.19% | -19.88% | -2947.83% | -87.03% | -53.67% | -73.01% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -380K | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.95% | 0% |
| Net Income | -37.94M | -37.28M | -35.11M | -41.34M | -56.57M | -50.7M | -10.75M | -12.92M | 102.88M | -79.65M | -39.64M | -42.87M |
| Net Margin % | -308.2% | -292.42% | -303.42% | -403.11% | -744.43% | -93.63% | -15.19% | -19.88% | 4457.32% | -87.03% | -53.16% | -73.01% |
| Net Income Growth % | 32.93% | 26.47% | -226.56% | -219.91% | -154.99% | 36.35% | 72.88% | 69.86% | 235.85% | -35.3% | 54.25% | 14.52% |
| Net Income (Continuing) | -36.94M | -46.35M | -44.52M | -44.86M | -47.4M | -50.7M | -10.75M | -12.92M | -68.04M | -79.65M | -39.64M | -42.87M |
| Discontinued Operations | -1000K | 1000K | 1000K | 1000K | -1000K | 0 | 0 | 0 | 1000K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.28 | -0.31 | -0.30 | -0.39 | -0.49 | -0.44 | -0.09 | -0.11 | 0.82 | -0.71 | -0.41 | -0.49 |
| EPS Growth % | 42.86% | 29.55% | -221.54% | -254.55% | -159.76% | 38.03% | 77.24% | 77.55% | 187.23% | 16.47% | 65.55% | 32.88% |
| EPS (Basic) | -0.28 | -0.31 | -0.30 | -0.39 | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 | -0.71 | -0.41 | -0.49 |
| Diluted Shares Outstanding | 136.4M | 120.37M | 116.23M | 116.08M | 115.86M | 115.42M | 115.21M | 114.82M | 125.53M | 111.49M | 97.74M | 87.27M |
| Basic Shares Outstanding | 136.4M | 120.37M | 116.23M | 116.08M | 115.86M | 115.42M | 115.21M | 114.82M | 112.75M | 111.49M | 97.74M | 87.27M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |